Kineta (STU:J75) General and Admin. Expense : €10.98 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kineta General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Kineta's General and Admin. Expense for the three months ended in Mar. 2024 was €3.39 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €10.98 Mil.

Kineta General and Admin. Expense Historical Data

The historical data trend for Kineta's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta General and Admin. Expense Chart

Kineta Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

3.61

4.09

8.21

11.13

Kineta Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
General and Admin. Expense	Get a 7-Day Free Trial							3.67	3.17	1.95	2.49	3.39

Kineta General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.98 Mil.

Kineta General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Kineta's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kineta (STU:J75) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

KA:USA

Address

219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109

Website

https://www.kinetabio.com

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines